×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Global Pediatric Development: We Are Making Progress
Session Chair(s)
Chin Koerner, MS
Executive Director, Development and Regulatory Policy
Novartis , United States
Representatives from the US Food and Drug Administration (FDA), European Medicines Agency (EMA), and Pharmaceutical and Medical Device Agency (PMDA) will provide the latest regional policy developments, share examples of similar policies and agreements and share examples where the agencies differ.
Learning Objective : Discuss the latest policy developments in the three regions in pediatric research.
Speaker(s)
Into the Future: Go Global Pediatric Development Forward for Children Worldwide — Beyond Current Regulations
Junko Sato, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Associate Executive Director
FDA Perspective
Mary Dianne Murphy, MD
FDA, United States
Director, Office of Pediatric Therapeutics, Office of Special Medical Programs
EMA Perspective
Jordi Llinares Garcia, MS
European Medicines Agency, Netherlands
Head of Research and Innovation
Have an account?